InsidersTradesSigma
Track the AB SCIENCE stock price and the full management transaction log of the company, a publicly traded company based in France. Shares are listed on the FR market, under the oversight of AMF. Operating in the Health Care sector, AB SCIENCE has logged 1 insider filings. Market capitalisation: €54.5m. The latest transaction was disclosed on 25 May 2026 (Cession). Among the most active insiders: Alain Moussy. Every trade is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€461
1 ops.
Sell Volume
30Σ signal
Fundamental score
Ranked 22,670 of 28,985 companies
32.0
score / 100
Value16
Quality48
FCF yld-6.5%
Earn yld-2.2%
EV/EBITDA53.1x
ROE·
Gross mgn83%
Net mgn·
Debt/EBITDA11.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 May 2026
Declarations1 total
573 shares@ €0.805100.0% of flowActioncession en bloc hors euronext via la plateforme de negociation electronique BATSISIN FR00105572642026DD1116377
1 of 1 declaration
About AB SCIENCE
AB SCIENCE is a French biopharmaceutical company focused on developing treatments for serious diseases. It primarily concentrates on therapies based on proteins and monoclonal antibodies.